Hydrocephalus is an excess of cerebrospinal fluid (CSF) in the brain’s ventricles. Surgery is the first-line and most effective treatment. The two primary surgeries are the Ventriculoperitoneal (VP) ...

Madison Scientific (MadSci) is an early-stage medical device company innovating smart electro-mechanical devices to improve treatment and long-term care for patients with hydrocephalus and other ...

Hydrocephalus, a neurological condition marked by the excessive accumulation of cerebrospinal fluid (CSF) within the brain’s ventricles, presents significant clinical challenges. Traditional ...

Use of an eye ultrasound may quickly and safely identify children with brain drainage tube failure in the emergency department, according to a new study. The research will be presented at the ...

FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial. In its premarket approval application for the ...

10 patients enrolled with 100% implantation success Adona's adjustable interatrial shunt is designed so it can be modified post-implantation to provide a more adaptive and personalized lifetime ...

Johnson & Johnson’s billion-dollar bet on a novel implant for heart failure hit a roadblock this week, with an FDA advisory panel unanimously voting against its risk-benefit profile. The V-Wave ...